| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 374633-38-2 | 2-Bromo-5-fluoro-6-methylpyridine | C6H5BrFN |
| 374703-78-3 | PKG drug G1 | C13H11N3OS |
| 374706-74-8 | 3-Hydroxymethyl-6-methyl-2(1H)-pyridinone | C7H9NO2 |
| 374726-44-0 | 6-Deoxy-L-galactopyranose 1-(dihydrogen phosphate) disodium salt | C6H11O8PNa2 |
| 374726-62-2 | Mandipropamid | C23H22ClNO4 |
| 374750-30-8 | 2'-C-Methylguanosine | C11H15N5O5 |
| 374777-77-2 | N-[4-[1-[(2,4-Diamino-6-pteridinyl)methyl]-3-butynyl]benzoyl]-L-glutamic acid dimethyl ester | C25H27N7O5 |
| 374790-93-9 | 2-Furanboronic acid pinacol ester | C10H15BO3 |
| 374790-97-3 | 4-Bromo-3-fluorophenylboronic acid | C6H5BBrFO2 |
| 374790-98-4 | (2-Fluoro-4-iodophenyl)boronic acid | C6H5BFIO2 |
| 374790-99-5 | [4-Bromo-2,3-difluorophenyl]boronic acid | C6H4BBrF2O2 |
| 374791-01-2 | Fmoc-(S)-3-Amino-3-(3-nirtophenyl)propionic acid | C24H20N2O6 |
| 374791-04-5 | Fmoc-(R)-3-Amino-3-(3-nirtophenyl)propionic acid | C24H20N2O6 |
| 374791-05-6 | (3R,6R)-2,7-Dimethyl-3,6-octanediol | C10H22O2 |
| 374794-77-1 | 4-Methyl-3-oxo-1-piperidinecarboxylic acid tert-butyl ester | C11H19NO3 |
| 374794-84-0 | 4,4-Bis(hydroxymethyl)piperidine-1-carboxylic acid tert-butyl ester | C12H23NO4 |
| 374794-89-5 | tert-Butyl 1-oxa-8-azaspiro[4.5]decane-8-carboxylate | C13H23NO3 |
| 374794-96-4 | 1,1-Dimethylethyl 2-Oxa-8-azaspiro[4.5]decane-8-carboxylate | C13H23NO3 |
| 374796-72-2 | L-alpha-Aspartyl-L-alanyl-L-alpha-glutamyl-L-phenylalanyl-L-arginyl-L-histidyl-L-alpha-aspartyl-L-serylglycyl-L-tyrosyl-L-alpha-glutamyl-L-valyl-L-histidyl-L-histidyl-L-glutaminyl-L-lysyl-L-leucyl-L-valyl-L-phenylalanyl-L-phenylalanyl-L-alanyl-L-alpha-glutamyl-L-asparaginyl-L-valylglycyl-L-seryl-L-asparaginyl-L-lysylglycyl-L-alanyl-L-isoleucyl-L-isoleucylglycyl-L-leucyl-L-methionyl-L-valylglycylglycyl-L-valyl-L-valine | C194H296N54O57S |
| 374822-27-2 | alpha-Methyl-3,5-bis(trifluoromethyl)benzenemethanamine hydrochloride | C10H9F6N.HCl |
| 374898-00-7 | 1-Benzyl-4-methylpiperazine hydrochloride | C12H19ClN2 |
| 374898-01-8 | (R)-1-(4-Fluorophenyl)ethylamine | C8H10FN |
| 374899-60-2 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-6-hydroxy-L-norleucine | C21H23NO5 |
| 374913-63-0 | 2-[(7-Methoxy-4-methyl-2-quinazolinyl)amino]-5,6-dimethyl-4(3H)-pyrimidinone | C16H17N5O2 |
| 374929-20-1 | (2S)-N-Boc-5-methylpyrrolidine-2-carboxylic acid | C11H19NO4 |
| 374934-98-2 | 3-Bromo-5-(4-methoxyphenoxy)pyridine | C12H10BrNO2 |
| 374935-00-9 | 3-Bromo-5-(3-methoxyphenoxy)pyridine | C12H10BrNO2 |
| 374935-03-2 | 3-Bromo-5-(4-fluorophenoxy)pyridine | C11H7BrFNO |
| 375345-95-2 | Mibampator | C21H30N2O4S2 |
| 375348-49-5 | Bertilimumab | |
| 375368-78-8 | 3-Bromo-2-fluoro-6-methylpyridine | C6H5BrFN |
| 375368-80-2 | 3-Fluoro-2-methoxy-6-picoline | C7H8FNO |
| 375368-83-5 | 3-Bromo-6-fluoro-2-methylpyridine | C6H5BrFN |
| 375368-84-6 | 5-Chloro-2-fluoro-3-methylpyridine | C6H5ClFN |
| 375368-85-7 | 5-Cyano-2-fluoro-6-methylpyridine | C7H5FN2 |
| 375368-86-8 | 2-Methoxy-5-fluoro-6-methylpyridine | C7H8FNO |
| 375369-03-2 | 4-Bromo-1H-indol-6-amine | C8H7BrN2 |
| 375369-14-5 | 6-Bromobenzoxazole | C7H4BrNO |
| 375395-33-8 | Trioctylmethylammonium bis(trifluoromethylsulfonyl)imide | C25H54N.C2F6NO4S2 |
| 375815-87-5 | Varenicline tartrate | C13H13N3.C4H6O6 |
| 375822-19-8 | D-Ala-Lys-AMCA | C21H28N4O6 |
| 375823-41-9 | Tocilizumab | |
| 375846-25-6 | tert-Butyl (E)-7-[3'-(4''-fluorophenyl)-1'-methylethyl-indol-2'-yl]-3-hydroxy-5-oxo-6-heptenoate | C28H32FNO4 |
| 375853-79-5 | tert-Butyl 5-iodopyridin-2-ylcarbamate | C10H13IN2O2 |
| 375853-82-0 | 1,2,3,6-Tetrahydropyridine-4-boronic acid pinacol ester | C11H20BNO2 |
| 375853-98-8 | tert-Butyl [1-(3-bromophenyl)ethyl]carbamate | C13H18BrNO2 |
| 375857-65-1 | 3-Bromo-7-(trifluoromethyl)imidazo[1,2-a]pyrimidine | C7H3BrF3N3 |
| 375857-66-2 | 7-Trifluoromethylimidazo[1,2-a]pyrimidine | C7H4F3N3 |
| 376348-65-1 | Maraviroc | C29H41F2N5O |
| 376348-67-3 | N-(8-Benzyl-8-azabicyclo[3.2.1]oct-3-yl-exo)-2-methylpropanamide | C18H26N2O |